Maternal serum ADAM12s as a potential marker of trisomy 21 prior to 10 weeks of gestation

Prenatal Diagnosis

Volumn 28, Issue 3, 2008, Pages 209-211

  Spencer, Kevin ^a,b   Vereecken, Annie ^c   Cowans, Nicholas J ^a  

^a KING GEORGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Algemeen Medisch Laboratorium   (Belgium)

Author keywords

Aneuploidy; Free hCG; Growth factors; PAPP A; Screening

Indexed keywords

ADAM PROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; GLYCOPROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 6E6; MONOCLONAL ANTIBODY 8F8; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DELFIA ASSAY; DISEASE MARKER; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RANK SUM TEST; SCREENING TEST; SECOND TRIMESTER PREGNANCY; TRISOMY 21;

ADAM PROTEINS; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; MEMBRANE PROTEINS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; SENSITIVITY AND SPECIFICITY;

EID: 41149119868     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1939     Document Type: Article

References (15)

1. Christiansen M, Spencer K, Laigaard J, Cowans NJ, Larsen SO, Wewer UM. 2007. ADAM12 as a second trimester maternal serum markers in screening for Down's syndrome. Prenat Diagn 27: 611-615.
2. Cowans NJ, Spencer K. 2007. First trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 27: 264-271.
3. Gilpin BJ, Loechel F, Mattei MG, Engvall E, Albrechtsen R, Wewer UM. 1998. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem 273: 157-166.
4. Gyselaers W, Vereecken A, Van Herck E, et al. 2005. Population screening for fetal trisomy 21: easy access to screening should be balanced against a uniform ultrasound protocol. Prenat Diagn 25: 984-990.
5. Laigaard J, Sorensen T, Fröhlich C, et al. 2003. ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenat Diagn 23: 1086-1091.
6. Laigaard J, Christiansen M, Frohlich C, Pedersen BN, Ottesen B, Wewer UM. 2005a. The level of ADAM12 in maternal serum is an early first-trimester marker of fetal trisomy 18. Prenat Diagn 25: 45-46.
7. Laigaard J, Sorensen T, Placing S, et al. 2005b. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynecol 106: 144-149.
8. Laigaard J, Cuckle H, Wewer UM, Christiansen M. 2006a. Maternal serum ADAM12 levels in Down's and Edwards' syndrome pregnancies at 9-12 weeks gestation. Prenat Diagn 26: 689-691.
9. Laigaard J, Spencer K, Christiansen M, et al. 2006b. ADAM 12 as a first trimester maternal serum marker in screening for Down syndrome. Prenat Diagn 26: 973-979.
10. Loechel F, Fox JW, Murphy G, Albrechtsen R, Wewer UM. 2000. ADAM 12 cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 278: 511-515.
11. Shi Z, Xu W, Loechel F, Wewer UM, Murphy LJ. 2000. ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3. J Biol Chem 275: 18574-18580.
12. Spencer K, Cowans NJ. 2007. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy. J Matern Fetal Neonat Med 20: 645-650.
13. Spencer K, Cowans NJ, Stamatopoulou A. 2007. Maternal serum ADAM12s as a marker of rare aneuploides in the first or second trimester of pregnancy. Prenat Diagn 27: 1233-1237.
14. Spencer K, Cowans NJ, Stamatopoulou A. 2008. Maternal serum ADAM12s in the late first trimester of pregnancies with Trisomy 21. Prenat Diagn. In press.
15. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy associated plasma protein-A. Ultrasound Obstet Gynaecol 13: 231-237.